Literature DB >> 10510206

Cell biology of Paget's disease.

S V Reddy1, C Menaa, F R Singer, A Demulder, G D Roodman.   

Abstract

Paget's disease is characterized by markedly increased osteoclast formation and bone resorption followed by excessive new bone formation. Osteoclasts in Paget's disease are increased both in number and size, contain paramyxoviral-like nuclear inclusions, and can have up to 100 nuclei per cell. Marrow culture studies have identified several abnormalities in osteoclast formation in Paget's disease. Osteoclast-like multinucleated cells formed more rapidly in marrow cultures from patients with Paget's disease, produced increased levels of interleukin-6 (IL-6), and expressed high levels of IL-6 receptors compared to normals. IL-6 levels were also increased in bone marrow and peripheral blood of patients with Paget's disease. In addition, osteoclast precursors from patients with Paget's disease are hyperresponsive to 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) and calcitonin. The increased sensitivity of osteoclast precursors to 1,25(OH)2D3 is mediated through the vitamin D receptor (VDR), since 24-hydroxylase activity is also up-regulated at concentrations of 1,25(OH)2D3 that are one log less than that needed to induce 24-hydroxylase activity in osteoclast precursors from normals. However, VDR numbers and affinity for 1,25(OH)2D3 do not differ in osteoclast precursors from Paget's patients compared to those from normals. Synergistic interactions between cytokines such as IL-6 and 1,25(OH)2D3 also cannot explain the enhanced sensitivity of osteoclast precursors from patients with Paget's disease to 1,25(OH)2D3. Interestingly, coculture studies of osteoclast precursors and cells from the marrow microenvironment of patients with Paget's disease and normals have demonstrated that the marrow microenvironment is more osteoclastogenic than normal. Thus, studies of the cell biology of osteoclasts in Paget's disease have demonstrated an increased rate of osteoclast formation and abnormalities in both osteoclast precursors and the marrow microenvironment. Enhanced IL-6 production by osteoclasts in Paget's disease may further amplify the increased osteoclast formation already ongoing in the pagetic lesion, and may explain the increased bone turnover at uninvolved sites distant from the pagetic lesion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10510206     DOI: 10.1002/jbmr.5650140203

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  10 in total

1.  RANKing the importance of measles virus in Paget's disease.

Authors:  F P Ross
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

Review 2.  Circulating monocytes: an appropriate model for bone-related study.

Authors:  Y Zhou; H-W Deng; H Shen
Journal:  Osteoporos Int       Date:  2015-07-21       Impact factor: 4.507

3.  NFAM1 signaling enhances osteoclast formation and bone resorption activity in Paget's disease of bone.

Authors:  Yuvaraj Sambandam; Kumaran Sundaram; Takamitsu Saigusa; Sundaravadivel Balasubramanian; Sakamuri V Reddy
Journal:  Bone       Date:  2017-05-12       Impact factor: 4.398

4.  Ketopremithramycins and ketomithramycins, four new aureolic acid-type compounds obtained upon inactivation of two genes involved in the biosynthesis of the deoxysugar moieties of the antitumor drug mithramycin by Streptomyces argillaceus, reveal novel insights into post-PKS tailoring steps of the mithramycin biosynthetic pathway.

Authors:  Lily L Remsing; Jose Garcia-Bernardo; Ana Gonzalez; Eva Künzel; Uwe Rix; Alfredo F Braña; Daniel W Bearden; Carmen Méndez; Jose A Salas; Jürgen Rohr
Journal:  J Am Chem Soc       Date:  2002-02-27       Impact factor: 15.419

5.  Increased resorptive activity and accompanying morphological alterations in osteoclasts derived from the oim/oim mouse model of osteogenesis imperfecta.

Authors:  Hao Zhang; Stephen B Doty; Christine Hughes; David Dempster; Nancy Pleshko Camacho
Journal:  J Cell Biochem       Date:  2007-11-01       Impact factor: 4.429

6.  Bone loss in survival motor neuron (Smn(-/-) SMN2) genetic mouse model of spinal muscular atrophy.

Authors:  Srinivasan Shanmugarajan; Eichi Tsuruga; Kathryn J Swoboda; Bernard L Maria; William L Ries; Sakamuri V Reddy
Journal:  J Pathol       Date:  2009-09       Impact factor: 7.996

7.  Integrative Analysis of Transcriptomic and Epigenomic Data to Reveal Regulation Patterns for BMD Variation.

Authors:  Ji-Gang Zhang; Li-Jun Tan; Chao Xu; Hao He; Qing Tian; Yu Zhou; Chuan Qiu; Xiang-Ding Chen; Hong-Wen Deng
Journal:  PLoS One       Date:  2015-09-21       Impact factor: 3.240

8.  The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts.

Authors:  Hyunsoo Kim; Matthew C Walsh; Noriko Takegahara; Sarah A Middleton; Hong-In Shin; Junhyong Kim; Yongwon Choi
Journal:  Sci Rep       Date:  2017-03-15       Impact factor: 4.379

Review 9.  Roles of the RANKL-RANK Axis in Immunity-Implications for Pathogenesis and Treatment of Bone Metastasis.

Authors:  Bo Li; Pengru Wang; Jian Jiao; Haifeng Wei; Wei Xu; Pingting Zhou
Journal:  Front Immunol       Date:  2022-03-21       Impact factor: 7.561

Review 10.  Update on the pathogenesis and genetics of Paget's disease of bone.

Authors:  Luigi Gennari; Domenico Rendina; Daniela Merlotti; Guido Cavati; Christian Mingiano; Roberta Cosso; Maria Materozzi; Filippo Pirrotta; Veronica Abate; Marco Calabrese; Alberto Falchetti
Journal:  Front Cell Dev Biol       Date:  2022-08-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.